argyrotsipi/train-dataset huggingface dataset:
Covid-19 Update — House of Commons, 2021-07-06
Topic: Health
Mary Elizabeth Twist (Labour, Centre-left): The Secretary of State has already acknowledged the importance of dealing with the mental health problems we have seen arise in this pandemic, and it is now urgent that the issue is addressed, so when will the Government publish a clear statement on where Public Health England’s vital public mental health and suicide prevention work will sit in the new arrangements for our national public health system?
Covid-19 Update — House of Commons, 2021-07-06
Topic: Health
Florence Eshalomi (Labour, Centre-left): More than a quarter of my Vauxhall constituents are aged between 20 and 29 and many of them have not had the chance to come forward for their second vaccine. Obviously, the lockdown restrictions that we are under will ease in two weeks’ time. This morning, the Secretary of State has confirmed that numbers are expected to rise after 19 July. He will be aware that a number of young people—one in eight—are still vaccine-hesitant. We know about the link between cases and hospitalisation and that the link is not broken. Young people are fearful of getting long covid, so can the Minister inform the House what specific resources are being made available through the NHS for those suffering with long covid?
Covid-19 Update — House of Commons, 2021-07-06
Topic: Health
Matthew Raymond Western (Labour, Centre-left): The Secretary of State stated quite rightly last week that he was looking at the numbers very carefully immediately after being appointed. No doubt he will have looked at Japan and Korea, where the death rates are something like 2% or 5% of the UK’s death rate. Case rates are currently eight or nine per 100,000 in Korea and Japan, yet those countries—certainly Korea—are still mandating the wearing of masks. In the light of that, what does the Secretary of State think we should be doing, because those places are clearly having success?
Covid-19 Update — House of Commons, 2021-07-06
Topic: Health
Charlotte Louise Nichols (Labour, Centre-left): The pandemic is not over, and learning to live with the virus means putting in place measures to reduce risk. Flamefast, based in Woolston Grange in Warrington North, manufactures CO2 monitors that alongside measures such as air filtration and improved ventilation can help dramatically to reduce the risk of indoor transmission of the virus. Why has the Secretary of State ignored calls from the Labour party to put in place measures such as air filtration, improved ventilation and CO2 monitoring to reduce the risk in indoor confined spaces, particularly in hospitals and care homes, for the most vulnerable in our communities, which could help to save lives and to give a vital boost to our manufacturing sectors?
Covid-19 Update — House of Commons, 2021-07-06
Topic: Health
Anthony Joseph Lloyd (Labour, Centre-left): The Health Secretary has referred to the pressures on our GPs and our hospitals from non-covid patients, and that is of course real. Most health professionals—doctors, nurses and others—have been double-jabbed and regularly use at least the lateral flow test to ensure that they are not infected with covid. However, one of the local hospitals in my constituency, Fairfield General Hospital, tells me that some 30% of doctors were not available recently because they had been pinged as they had, not surprisingly, come into contact with somebody with covid. This happened not because they found they were infected but because they had to go into quarantine for the 10-day period. We risk a build-up of cases when we increase the number of times that our medical professionals are likely to find themselves pinged. Will he see whether there is some way, at least for medical staff, of bringing forward the August date?
Innovative Drugs and Medical Devices — House of Commons, 2017-02-07
Topic: Health
Andrew Richard Rosindell (Conservative, Centre-right): I know that the Minister will agree with me when I say that it is vital that we endeavour to ensure that the NHS gets better value for money for the drugs bill so that we can afford to get more of the latest innovative products to patients more quickly, but does she also agree that much more work needs to be done alongside the accelerated access review and the forthcoming life sciences strategy to achieve that objective?
Innovative Drugs and Medical Devices — House of Commons, 2017-02-07
Topic: Health
Nicola Blackwood (Conservative, Centre-right): I completely agree with my hon. Friend. Medicines are the second highest area of spending in the NHS after staff, and it is vital that the NHS gets best value from that investment. That is why I am pleased that the House supported our recent Bill on the cost of medicines and medicine supplies, which will enable us to tackle unjustified price rises for unbranded generic medicines. We are also working closely with NHS England to promote the use of the new wave of biosimilar medicines and to ensure cost-effective prescribing behaviour.
Innovative Drugs and Medical Devices — House of Commons, 2017-02-07
Topic: Health
Questions: As the Health Secretary is aware, my constituent Abi Longfellow is suffering with a rare kidney condition—dense deposit disease. What plans do the Government have to increase access to specialist drugs for those such as Abi with ultra-rare diseases?
Nicola Blackwood (Conservative, Centre-right): The National Institute for Health and Care Excellence and NHS England are working together to better manage access to new drugs and medical technologies for rare diseases. We are also working on the UK strategy for rare diseases and its implementation. It has 51 commitments to be implemented by 2020 to improve the lives of constituents such as my hon. Friend’s.
Innovative Drugs and Medical Devices — House of Commons, 2017-02-07
Topic: Health
Questions: As the Health Secretary is aware, my constituent Abi Longfellow is suffering with a rare kidney condition—dense deposit disease. What plans do the Government have to increase access to specialist drugs for those such as Abi with ultra-rare diseases?
Nicola Blackwood (Conservative, Centre-right): I thank the hon. Gentleman for drawing our attention to this issue. Sometimes the simplest solutions are the most effective. We want to make sure that such innovations are driven across the NHS more effectively, which is exactly what our academic health service networks are there for.
Covid-19: Education Settings — House of Commons, 2021-07-06
Topic: Health
Clive Stanley Efford (Labour, Centre-left): The Secretary of State has told us that there will be a spike in infections following the relaxing of restrictions, and currently there are 150,000 school pupils with suspected covid-19 that are out of school, so we know that that figure will go up. So this is not about children dying of the infection; it is about schools being a vector for infection. What is the Secretary of State going to do when the winter months are coming, and we have increasing numbers of infections, to ensure that that does not happen, by improving ventilation and assisting schools with the resources that they need to deliver a safer environment?
Covid-19: Education Settings — House of Commons, 2021-07-06
Topic: Health
Rachael Helen Maskell (Labour, Centre-left): As the data show, in York infection rates are soaring, particularly in school-age children, people are poorly, and as a result we are seeing major disruption in young people’s education. So as we see infection rates soar across the country, it means that education will be further disrupted, and I hope that the Secretary of State recognises that. How would he ensure that effective testing is put in place, working with our public health teams on the ground locally, to mitigate against that spike in infections and ensure that young people and their families are supported when they have to isolate and miss school?
Breast Cancer Drugs — House of Commons, 2017-02-07
Topic: Health
Nicola Blackwood (Conservative, Centre-right): The hon. Lady and I have debated this in the House before. It is worth looking at our record. The cancer drugs fund has helped 95,000 people to access cancer drugs, to the tune of £1.2 billion, and NICE has approved three breast cancer drugs, while there are others that it has not yet approved. It is important that politicians do not intervene in this debate, as these are very difficult decisions that will always be challenging in the situation where the NHS has a finite budget.
Breast Cancer Drugs — House of Commons, 2017-02-07
Topic: Health
Questions: I am delighted to do so, Mr Speaker—thank you very much. Given that there is no general hospital in my constituency and a large number of my constituents have to travel many miles for cancer treatment, what discussions has my hon. Friend had with the Welsh Government to persuade them to fund mobile cancer treatments?
Johanna Peta Churchill (Conservative, Centre-right): Does the Minister agree that not one subject that we have discussed today would not be improved by the better transfer of patient data? How is the Department working towards linking social care with the acute sector, with GPs, with mental health services, with innovation and with cancer drugs in order to understand where we can best target patient outcomes and spend our resources?
Breast Cancer Drugs — House of Commons, 2017-02-07
Topic: Health
Questions: I am delighted to do so, Mr Speaker—thank you very much. Given that there is no general hospital in my constituency and a large number of my constituents have to travel many miles for cancer treatment, what discussions has my hon. Friend had with the Welsh Government to persuade them to fund mobile cancer treatments?
Nicola Blackwood (Conservative, Centre-right): My hon. Friend has a leading role with her private Member’s Bill so she is well aware that we are working very hard to improve the connection of patient data, particularly through the role of the national data guardian and her 10 safeguarding rules, which will make sure that we not only protect patient data more effectively but are able to share it in an effective way that improves patient care.
Covid-19: Education Settings — House of Commons, 2021-07-06
Topic: Health
Mary Elizabeth Twist (Labour, Centre-left): For many months now, school leaders have been spending a lot of their time on weekends making contacts when they are notified that someone has covid-19, so I am glad that some of that responsibility will be shifted to NHS Test and Trace, but will the Secretary of State clarify exactly what the relationship will be, given the references in the guidance to settings still having a role to play in that situation?
Nursing — House of Commons, 2017-02-07
Topic: Health
Philip Martin Dunne (Conservative, Centre-right): We have announced the first 1,000 nursing associates. In fact, the first cohort commenced at the beginning of this month. I visited, in Queen’s hospital, Romford, the first very enthusiastic group of nursing associates. We have announced a second wave of 2,000 associate roles. I regret to say that Wiltshire does not have any of those at the moment, but that will not stop it bidding for them in future. I will look at my hon. Friend’s point about further education colleges.
Nursing — House of Commons, 2017-02-07
Topic: Health
Philip Martin Dunne (Conservative, Centre-right): I urge the right hon. Gentleman not to indulge in scaremongering about the number of people applying to become nurses. There are more than two applications for each of the nursing places on offer to start next August. He needs to be careful about interpreting this early the figure for applications from EU nationals, which has gone down significantly, because it coincided with the introduction of the language test for EU nationals.
Nursing — House of Commons, 2017-02-07
Topic: Health
Philip Martin Dunne (Conservative, Centre-right): There are over 13,000 more nurses working in the NHS today than there were in May 2010. As I have just said to the hon. Lady, the language test came into effect from July last year, since when the number of applicants has been somewhat steady. It is down very significantly, but that is because, frankly, we have had applications from nurses from EU countries who have not been able to pass the language test.
Housing and Planning Bill — House of Lords, 2016-03-22
Topic: Culture
Rachel Trixie Anne Gardner (Conservative, Centre-right): My Lords, I have listened and have been most interested, and I agree with most of what has been said. The only thing I am unhappy about is that phrase "place making". The noble Lord mentioned heritage, which is very important because we are creating heritage for the future. "Place making", however, seems a pretty dull phrase, and I hope that by the time we get to Report, noble Lords may come up with something better.
Prostate Cancer — House of Commons, 2017-02-07
Topic: Health
Questions: What proportion of prostate cancer patients wait for more than two months to begin cancer treatment after the hospital has received an urgent GP referral.
David Mowat (Conservative, Centre-right): More information was published on cancer by clinical commissioning groups since the back end of last year than at any time in the history of the NHS. [Interruption.] The hon. Gentleman is right to say that prostate is grouped with neurological cancers in general, and that is the type of surgeon being employed. But the fact is that the Government have been incredibly transparent in terms of information published on cancers.
Prostate Cancer — House of Commons, 2017-02-07
Topic: Health
Questions: What proportion of prostate cancer patients wait for more than two months to begin cancer treatment after the hospital has received an urgent GP referral.
David Mowat (Conservative, Centre-right): The volume has increased greatly, and there are something like 2,000 more people being diagnosed every day. The hon. Lady is right: of the eight cancer standards against which we judge ourselves, we meet seven, and the 62-day one has not been met. We need to do more to achieve that, and the cancer strategy set out a pathway for doing so. We have particularly invested in the early diagnosis component; we have invested £200 million in early diagnosis and getting a 31-day all-clear or referral for treatment. That is the pathway to meeting the 62-day target. She is right to raise this, because it is an important indicator and we need to do better.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): We know that a strong primary care system is the bedrock of the NHS, which is why I am pleased to announce today that NHS England will publish the new GP contract, agreed by the Government, NHS England and the British Medical Association. It will see almost £240 million extra invested in GP services; require GPs to establish whether overseas visitors are eligible for free care, allowing the NHS to better recoup the costs of that care; and improve access for patients by removing extra funding if GPs regularly close for afternoons during the working week.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Pauline Elizabeth Latham (Conservative, Centre-right): Will the Secretary of State consider putting a GP in every A&E department so that they can additionally triage patients who are not so ill and advise them to go home and see their own GP on another occasion?
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): My hon. Friend is absolutely right. Actually, the policy is that all A&Es, where space is available, should do that. The hospitals that do it have by far the most successful results—not least Luton and Dunstable, which has pioneered that model.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): The NHS is under a lot of pressure, but what we never get from the hon. Gentleman is any solutions. Our solution is 600 more A&E consultants since 2010, 1,500 more A&E doctors, 2,000 more paramedics, and 2,500 more people being seen within four hours every day. His solution at the last election was to cut the NHS budget by £1.3 billion.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): Let us look at the reality, instead of the hon. Gentleman’s rhetoric. In his own local trust in Leicester, there are 246 more nurses than in 2010 and 313 more doctors. Some 185 more patients are being seen in A&E every day and next year a new £43 million emergency floor will open at the Leicester Royal Infirmary. That is because we are backing the NHS instead of wanting to cut its budget.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Questions: The recently introduced one-year cancer survival rate indicator is a beacon of light in a system still too focused on process targets. What more can the Government do to hold underperforming clinical commissioning groups to account for that outcome indicator, given that we are still failing to catch up with international averages when it comes to our survival rates?
David Mowat (Conservative, Centre-right): My hon. Friend is right to say that we now publish one-year survival rates for every CCG in the country, and I agree that that is a beacon of light and a transformative step. It also shows differences of more than 10% between the best and the worst, which is unacceptable. The transparency itself will bring improvement, but we have also recently established 16 cancer alliances, whose sole job is to roll out best practice and investigate and bear down on poor performance.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Questions: The recently introduced one-year cancer survival rate indicator is a beacon of light in a system still too focused on process targets. What more can the Government do to hold underperforming clinical commissioning groups to account for that outcome indicator, given that we are still failing to catch up with international averages when it comes to our survival rates?
Jeremy Richard Streynsham Hunt (Conservative, Centre-right): The hon. Gentleman is absolutely right; this issue is a very big concern. The only way, in the long run, to reduce those litigation costs is to have safer care. That is why the Government have prioritised safety in everything we do.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Questions: The recently introduced one-year cancer survival rate indicator is a beacon of light in a system still too focused on process targets. What more can the Government do to hold underperforming clinical commissioning groups to account for that outcome indicator, given that we are still failing to catch up with international averages when it comes to our survival rates?; If someone in St Ives suffers a severe stroke, they will have a far better chance of a full recovery if they get quick treatment and then proper therapy and rehabilitation in the community. That does not happen for everybody. What is the Department going to do to ensure that there will be a national stroke strategy?
David Mowat (Conservative, Centre-right): The current stroke strategy was produced in 2007 and our priority is to implement it fully. Frankly, in my time as a Minister, I would prefer to have detailed implementation plans and not more strategies. My hon. Friend refers to the great differences in performance across the country, in particular in access to speech and language therapy, and we need to achieve better on that.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Questions: The recently introduced one-year cancer survival rate indicator is a beacon of light in a system still too focused on process targets. What more can the Government do to hold underperforming clinical commissioning groups to account for that outcome indicator, given that we are still failing to catch up with international averages when it comes to our survival rates?; If someone in St Ives suffers a severe stroke, they will have a far better chance of a full recovery if they get quick treatment and then proper therapy and rehabilitation in the community. That does not happen for everybody. What is the Department going to do to ensure that there will be a national stroke strategy?; My Falkirk constituents, Michelle and Justin Young, have been through the lengthy treatment approval process for their son, Michael, to access the Duchenne muscular dystrophy treatment Translarna. Thankfully, Michael is now receiving it. With a growing number of emerging treatments for rare diseases expected in the forthcoming years, what action are the Government taking to increase the capacity of the Medicines and Healthcare Products Regulatory Agency when the UK leaves the EU? Most importantly, will the Secretary of State or the Minister agree to meet Muscular Dystrophy UK—
Nicola Blackwood (Conservative, Centre-right): I pay tribute to the work of the charity the hon. Gentleman mentioned, which does very important work, and have sympathy for the case he mentioned. The UK’s rare diseases strategy has 51 recommendations, which are driving changes through the NHS and improving the life chances of patients with rare diseases. Our genomics work is also bringing life-changing improvements to patients with rare diseases by diagnosing them faster and improving their chances of receiving treatment quicker.
Topical Questions — House of Commons, 2017-02-07
Topic: Health
Questions: The recently introduced one-year cancer survival rate indicator is a beacon of light in a system still too focused on process targets. What more can the Government do to hold underperforming clinical commissioning groups to account for that outcome indicator, given that we are still failing to catch up with international averages when it comes to our survival rates?; If someone in St Ives suffers a severe stroke, they will have a far better chance of a full recovery if they get quick treatment and then proper therapy and rehabilitation in the community. That does not happen for everybody. What is the Department going to do to ensure that there will be a national stroke strategy?; My Falkirk constituents, Michelle and Justin Young, have been through the lengthy treatment approval process for their son, Michael, to access the Duchenne muscular dystrophy treatment Translarna. Thankfully, Michael is now receiving it. With a growing number of emerging treatments for rare diseases expected in the forthcoming years, what action are the Government taking to increase the capacity of the Medicines and Healthcare Products Regulatory Agency when the UK leaves the EU? Most importantly, will the Secretary of State or the Minister agree to meet Muscular Dystrophy UK—; People in Lancashire will be pleased that the emergency department in Chorley has reopened, providing access for people 12 hours a day. Will my hon. Friend welcome that good news and thank everyone involved?
Philip Martin Dunne (Conservative, Centre-right): I am grateful to my hon. Friend for recognising the work that went into reopening the A&E at Chorley last month. I am delighted, in particular, by the work that was done by the Deputy Speaker and my hon. Friend the Member for South Ribble (Seema Kennedy).